Lilly Starts Phase 3 Trial for Antibody Treatment of COVID-19
by Brian Wang from NextBigFuture.com on (#56MRZ)
Eli Lilly a Phase 3 trial studying LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff at long-term care facilities in the U.S. (skilled nursing facilities,...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]